{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:11:24Z","timestamp":1790082684778,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"DOI":"10.1007\/s00115-026-02014-w","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:26:37Z","timestamp":1790079997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Station\u00e4re Behandlung von Abh\u00e4ngigkeitserkrankungen","Inpatient treatment of substance use disorders"],"prefix":"10.1007","author":[{"given":"Mandy","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljosha","family":"Deen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Porsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sch\u00f6neberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Strate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"2014_CR1","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (2020) S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener St\u00f6rungen, Version 3.1. (AWMF-Registernummer 076-001)"},{"key":"2014_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3325\/cmj.2008.49.842","volume":"49","author":"M Bilban","year":"2008","unstructured":"Bilban\u00a0M, Kastelic\u00a0A, Zaletel-Kragelj\u00a0L (2008) Ability to work and employability of patients in opioid substitution treatment programs in Slovenia. Croat Med J 49:842\u2013852","journal-title":"Croat Med J"},{"key":"2014_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/15598276251403469","author":"D Caples","year":"2025","unstructured":"Caples\u00a0D, Srivastava\u00a0S (2025) Pharmacotherapy for Alcohol Use Disorder: A\u00a0Brief Review of Available Options and Their Integration With Lifestyle Medicine Approaches. Am J Lifestyle Med. https:\/\/doi.org\/10.1177\/15598276251403469","journal-title":"Am J Lifestyle Med"},{"key":"2014_CR4","volume":"6","author":"N Casiano","year":"2025","unstructured":"Casiano\u00a0N, Casiano\u00a0N (2025) Comparative Effectiveness of Medication-Assisted Treatment (Mat) for Opioid Use Disorder in Residential Settings: A\u00a0Literature Review. J\u00a0Rehab Pract Res 6:180","journal-title":"J Rehab Pract Res"},{"key":"2014_CR5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S2215-0366(19)30222-6","volume":"6","author":"A Castillo-Carniglia","year":"2019","unstructured":"Castillo-Carniglia\u00a0A, Keyes\u00a0KM, Hasin\u00a0DS et\u00a0al (2019) Psychiatric comorbidities in alcohol use disorder. Lancet Psychiatry 6:1068\u20131080","journal-title":"Lancet Psychiatry"},{"key":"2014_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11469-017-9784-5","volume":"16","author":"H Dauber","year":"2018","unstructured":"Dauber\u00a0H, Braun\u00a0B, Pfeiffer-Gerschel\u00a0T et\u00a0al (2018) Co-occurring Mental Disorders in Substance Abuse Treatment: the Current Health Care Situation in Germany. Int J Ment Health Addict 16:66\u201380","journal-title":"Int J Ment Health Addict"},{"key":"2014_CR7","unstructured":"Deutsche Gesellschaft f\u00fcr Suchtmedizin e.\u202fV., Deutsche Gesellschaft f\u00fcr Suchtforschung und Suchttherapie e.\u202fV. (2025) S3-Leitlinie Opioidbezogene St\u00f6rungen, Version\u00a01.0."},{"key":"2014_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","volume":"5","author":"GBD 2016 Alcohol and Drug Use Collaborators","year":"2018","unstructured":"GBD 2016 Alcohol and Drug Use Collaborators (2018) The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a\u00a0systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry 5:987\u20131012","journal-title":"Lancet Psychiatry"},{"key":"2014_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","volume":"73","author":"BF Grant","year":"2016","unstructured":"Grant\u00a0BF, Saha\u00a0TD, Ruan\u00a0WJ et\u00a0al (2016) Epidemiology of DSM\u20115 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry 73:39\u201347","journal-title":"JAMA Psychiatry"},{"key":"2014_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-pharmtox-031323-115847","volume":"64","author":"GF Koob","year":"2024","unstructured":"Koob\u00a0GF (2024) Alcohol Use Disorder Treatment: Problems and Solutions. Annu Rev Pharmacol Toxicol 64:255\u2013275","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2014_CR11","first-page":"137","volume":"116","author":"L Kraus","year":"2019","unstructured":"Kraus\u00a0L, Seitz\u00a0NN, Schulte\u00a0B et\u00a0al (2019) Estimation of the Number of People With Opioid Addiction in Germany. Dtsch Arztebl Int 116:137\u2013143","journal-title":"Dtsch Arztebl Int"},{"key":"2014_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","volume":"108","author":"NC Maisel","year":"2013","unstructured":"Maisel\u00a0NC, Blodgett\u00a0JC, Wilbourne\u00a0PL et\u00a0al (2013) Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction 108:275\u2013293","journal-title":"Addiction"},{"key":"2014_CR13","volume-title":"Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors","author":"GA Marlatt","year":"2005","unstructured":"Marlatt\u00a0GA, Donovan\u00a0DM (2005) Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. Guilford Press, New York"},{"key":"2014_CR14","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/jama.2023.19761","volume":"330","author":"M McPheeters","year":"2023","unstructured":"McPheeters\u00a0M, O\u2019Connor\u00a0EA, Riley\u00a0S et\u00a0al (2023) Pharmacotherapy for Alcohol Use Disorder: A\u00a0Systematic Review and Meta-Analysis. JAMA 330:1653\u20131665","journal-title":"JAMA"},{"issue":"7","key":"2014_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/00952990.2021.1887202","volume":"2021","author":"E Moazen-Zadeh","year":"2021","unstructured":"Moazen-Zadeh\u00a0E, Ziafat\u00a0K, Yazdani\u00a0K et\u00a0al (2021) Impact of opioid agonist treatment on mental health in patients with opioid use disorder: a systematic review and network meta-analysis of randomized clinical trials. Am J Drug Alcohol Abuse 2021(7):280\u2013304","journal-title":"Am J Drug Alcohol Abuse"},{"key":"2014_CR16","unstructured":"National Institutes on Drug Abuse (US) (2020) Common Comorbidities with Substance Use Disorders Research Report. (Bethesda (MD); PMID:34185444)"},{"key":"2014_CR17","first-page":"625","volume":"122","author":"S Olderbak","year":"2025","unstructured":"Olderbak\u00a0S, Hollweck\u00a0R, Krowartz\u00a0EM et\u00a0al (2025) Konsum psychoaktiver Substanzen in Deutschland, Ergebnisse des Epidemiologischen Suchtsurveys (ESA) 2024. Dtsch Arztebl Int 122:625\u2013631","journal-title":"Dtsch Arztebl Int"},{"key":"2014_CR18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo Jr","year":"2021","unstructured":"Santo\u00a0T Jr, Clark\u00a0B, Hickman\u00a0M et\u00a0al (2021) Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis. JAMA Psychiatry 78:979\u2013993","journal-title":"JAMA Psychiatry"},{"key":"2014_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo\u00a0L, Barrio\u00a0G, Bravo\u00a0MJ et\u00a0al (2017) Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ 357:j1550","journal-title":"BMJ"},{"key":"2014_CR20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1517\/14728214.2010.500811","volume":"15","author":"M Soyka","year":"2010","unstructured":"Soyka\u00a0M, R\u00f6sner\u00a0S (2010) Emerging drugs to treat alcoholism. Expert Opin Emerg Drugs 15:695\u2013711","journal-title":"Expert Opin Emerg Drugs"},{"key":"2014_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00115-020-00954-5","volume":"92","author":"M Soyka","year":"2021","unstructured":"Soyka\u00a0M, R\u00f6sner\u00a0S (2021) Pharmakotherapie der Alkoholentw\u00f6hnung: Update und neue Entwicklungen [Pharmacotherapy of alcohol withdrawal: update and new developments]. Nervenarzt 92:57\u201365","journal-title":"Nervenarzt"},{"key":"2014_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJMra1511480","volume":"374","author":"ND Volkow","year":"2016","unstructured":"Volkow\u00a0ND, Koob\u00a0GF, McLellan\u00a0AT (2016) Neurobiologic Advances from the Brain Disease Model of Addiction. N Engl J Med 374:363\u2013371","journal-title":"N Engl J Med"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-02014-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-026-02014-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-02014-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:26:39Z","timestamp":1790079999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-026-02014-w"}},"subtitle":["Strukturen und Behandlungsstrategien: Ergebnisse einer bundesweiten Klinikbefragung","Structures and treatment strategies: results of a\u00a0nationwide survey of treatment facilities"],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":22,"alternative-id":["2014"],"URL":"https:\/\/doi.org\/10.1007\/s00115-026-02014-w","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"18 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Roy und P.\u00a0Strate: Beratert\u00e4tigkeiten f\u00fcr Sandoz\/Hexal. A.\u00a0Deen, J.\u00a0Porsch, D.\u00a0Bader und S.\u00a0Sch\u00f6neberger geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}